A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Public ClinicalTrials.gov record NCT01281631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study of NP001 in subjects with ALS.
Study identification
- NCT ID
- NCT01281631
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 136 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2011 (Type not available)
- Primary completion
- Sep 2012 (Actual)
- Completion
- Sep 2012 (Actual)
- Last update posted
- Nov 22, 2012
2011 – 2012
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic, Scottsdale | Scottsdale | Arizona | 85259 | — |
| UC, Irvine | Irvine | California | 92868-4281 | — |
| UCLA | Los Angeles | California | 90095 | — |
| California Pacific Med Center Forbes Norris MDA/ALS Research and Treatment Center | San Francisco | California | 94115 | — |
| Mayo Clinic, Jacksonville | Jacksonville | Florida | 32224 | — |
| The Emory Clinic | Atlanta | Georgia | 30322 | — |
| University of Kansas Medical Center, Landon Center on Aging | Kansas City | Kansas | 66160 | — |
| University of Kentucky, Department of Neurology | Lexington | Kentucky | 40536-0284 | — |
| Massachusetts General Hospital | Charlestown | Massachusetts | 02129 | — |
| Columbia University | New York | New York | 10032 | — |
| SUNY Upstate Medical University, Syracuse | Syracuse | New York | 13210 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28207 | — |
| Duke University, Dept of Neurology | Durham | North Carolina | 27705 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Providence ALS Center | Portland | Oregon | 97213 | — |
| Methodist Hospital Research Institute, Methodist Neurologic Institute | Houston | Texas | 77030 | — |
| Providence Saint Peter Hospital | Centralia | Washington | 98531 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01281631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2012 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01281631 live on ClinicalTrials.gov.